Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Operating activities
Net earnings	$ 3,347	$ 25,595
Items not affecting cash:
Depreciation and amortization	8,922	8,302
Amortization of debt issuance costs	939	655
Deferred income taxes	260	7,327
Stock-based compensation	2,447	(163)
Unrealized loss on derivative contracts	556	112
Gain on settlement of contingent consideration obligation	(2,286)	0
Gain on sale of business	0	(45,579)
Other	(90)	(62)
Changes in non-cash working capital, net of business sold	20,654	4,801
Net cash flows from operating activities	34,749	988
Investing activities
Purchases of property, plant and equipment	(9,689)	(7,974)
Net proceeds from sale of business		64,876
Net cash flows from investing activities	(9,689)	56,902
Financing activities
Decrease under line of credit facilities	(19,754)	(54,661)
Borrowings under long-term debt	155	1,852
Repayment of long-term debt	(597)	(723)
Payment of cash dividends on Series A Preferred Stock	(1,700)	(1,700)
Proceeds from the exercise of stock options and employee share purchases	101	228
Payment of debt issuance costs	(2,073)	(314)
Other	(4)	221
Net cash flows from financing activities	(23,872)	(55,097)
Foreign exchange loss on cash held in a foreign currency	(16)	(58)
Increase in cash and cash equivalents in the period	1,172	2,735
Cash and cash equivalents - beginning of the period	1,498	3,280
Cash and cash equivalents - end of the period	$ 2,670	$ 6,015